Model‐Informed Rationale for Early Therapeutic Drug Monitoring of Colistin in Critically Ill Patients-Reference-Cited by-同舟云学术

Model‐Informed Rationale for Early Therapeutic Drug Monitoring of Colistin in Critically Ill Patients

Published:2022-08-24 Issue:1 Volume:63 Page:57-65
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharma

Author:

Mathew Sumith K.¹,Rao Shoma V.²,Prabha Ratna¹,Neely Michael N.³,Mathew Binu Susan¹,Aruldhas Blessed Winston¹,Veeraraghavan Balaji⁴,Kandasamy Subramani²

Affiliation:

1. Department of Pharmacology and Clinical Pharmacology Christian Medical College The Tamilnadu Dr.M.G.R Medical University, Vellore Chennai India

2. Surgical Intensive Care Unit and Division of Critical Care Christian Medical College The Tamilnadu Dr.M.G.R Medical University, Vellore Chennai India

3. Department of Pediatrics Keck School of Medicine University of Southern California and Division of Infectious Diseases Children's Hospital Los Angeles CA USA

4. Department of Clinical Microbiology Christian Medical College The Tamilnadu Dr.M.G.R Medical University, Vellore Chennai India

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.2130

Reference25 articles.

1. Clinical Pharmacokinetics and Pharmacodynamics of Colistin

2. Colistin pharmacokinetics: the fog is lifting

3. New Colistin Population Pharmacokinetic Data in Critically Ill Patients Suggesting an Alternative Loading Dose Rationale

4. Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic predisposition and high exposure to colistin in the early treatment period as independent risk factors for colistin‐induced nephrotoxicity;Clinical and Translational Science;2024-03